GLP-1 TREATMENT OPTIONS

Semaglutide & Tirzepatide for Weight Loss

How each GLP-1 option works, what to expect, and how a licensed provider prescribes and monitors treatment.

Updated June 2026Medically reviewed by licensed providers

Weight Method offers two GLP-1 weight-loss options through licensed providers: compounded semaglutide and compounded tirzepatide. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GIP/GLP-1 receptor agonist. A licensed provider reviews your health profile and selects the option and dose that fit you, with ongoing monitoring. The compounded semaglutide program starts at $154/month and the compounded tirzepatide program at $329/month, all-inclusive. Compounded medications are not FDA-approved.

Key Fact

There is no single 'best' option for everyone. Your licensed provider selects between compounded semaglutide and tirzepatide based on your individual medical profile and monitors your response.

The Two GLP-1 Options

Semaglutide

Semaglutide is a GLP-1 receptor agonist. It acts on the pathways that regulate appetite and satiety. It is given as a weekly subcutaneous injection, with a gradual dose increase under provider supervision. Weight Method does not dispense brand-name products; our program uses compounded semaglutide prepared by a U.S.-licensed 503A compounding pharmacy.

Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist. It is also given as a weekly subcutaneous injection with dose escalation under provider supervision. Weight Method does not dispense brand-name products; our program uses compounded tirzepatide prepared by a U.S.-licensed 503A compounding pharmacy.

What Weight Method offers

Weight Method does not dispense or prescribe FDA-approved brand-name products. Our prescribing providers issue patient-specific prescriptions for compounded semaglutide or compounded tirzepatide, dispensed by U.S.-licensed 503A compounding pharmacies. The compounded semaglutide program starts at $154/month and the compounded tirzepatide program at $329/month, all-inclusive. Compounded medications are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality.

Find Your Best GLP-1 Option

Answer a few questions and a licensed provider will recommend the right medication for you.

Take the Free Quiz

Free consultation. No commitment.

Frequently Asked Questions

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist. They are distinct molecules with different profiles. There is no single 'best' option for everyone — your licensed provider reviews your medical profile and selects the option and dose that are appropriate for you.

You complete a medical questionnaire, a licensed provider reviews your information and, if clinically appropriate, issues a patient-specific prescription. The compounded medication is prepared by a U.S.-licensed 503A compounding pharmacy and shipped to your door, with ongoing provider monitoring.

The compounded semaglutide program starts at $154/month and the compounded tirzepatide program at $329/month, all-inclusive. Compounded medications are not FDA-approved.

Yes, with your provider's guidance. Switching requires dose adjustment and monitoring during the transition period.

Many patients notice changes in appetite within the first few weeks. Weight changes are gradual and vary by individual. Your provider follows up monthly and adjusts the plan based on your response.

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

More About GLP-1